Mehul Joshi
Vermögen: 118 848 $ am 31.08.2026
Vermögen: 118 848 $ am 31.08.2026
Mehul Joshi worked at ResMed, Inc. as Senior Vice President-Finance from 2011 to 2022.
In 2022 to 2023, worked at Bruker Cellular Analysis, Inc. as Chief Financial & Accounting Officer.
Served as Chief Financial Officer at Phenomebio, Inc. Also worked at Pulmonx Corp.
as Chief Financial Officer from 2024 to 2025.
Completed undergraduate and MBA degrees at Rutgers State University of New Jersey.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PULMONX CORP. 0.12% | 15.03.2026 | 49’936 ( 0.12% ) | 118 848 $ | 31.08.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| PULMONX CORPORATION | Finanzdirektor/CFO | 27.10.2025 |
| BRUKER CELLULAR ANALYSIS, INC. | Finanzdirektor/CFO | 02.10.2023 |
| RESMED, INC. | Corporate Officer/Principal | 01.07.2022 |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Develops and commercializes platforms for bio-pharmaceutical, genomic and cellular therapy applications | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
ResMed, Inc.
ResMed, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets devices for evaluation and treatment of sleep disorders | Health Technology |
Pulmonx Corp.
Pulmonx Corp. Medical SpecialtiesHealth Technology Develops and manufactures zephyr endobronchial valves for the treatment of emphysema | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Develops and commercializes platforms for bio-pharmaceutical, genomic and cellular therapy applications | Technology Services |
PhenomeX, Inc.
PhenomeX, Inc. Medical SpecialtiesHealth Technology Develops and sells products for cell therapy, functional analysis & antibody profiling services | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen